Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial
Abstract Background Psychotic disorders are a leading cause of disability in young adults. Antipsychotics have been the primary intervention for psychosis for over 60 years, and yet, we have made little progress in treating negative symptoms, neurocognition, and functional disability. There is growi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
BMC
2023-11-01
|
| Serija: | Trials |
| Teme: | |
| Online dostop: | https://doi.org/10.1186/s13063-023-07789-w |